Rotterdam, Netherlands

Menno Cornelis Van Zelm

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Menno Cornelis Van Zelm: Innovator in Immunodeficiency Diagnostics

Introduction

Menno Cornelis Van Zelm is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of immunology, particularly in the diagnosis of primary immunodeficiencies. With a total of 3 patents to his name, Van Zelm's work has advanced the understanding and diagnosis of complex immunological conditions.

Latest Patents

One of his latest patents focuses on reagents, methods, and kits for diagnosing primary immunodeficiencies. This invention specifically addresses the diagnosis of primary immunodeficiencies of the lymphoid system. The patent provides unique reagent compositions for flow cytometric immunophenotyping of leukocytes. These compositions include fluorochrome-conjugated antibodies that target various specific combinations of markers. Additionally, the patent encompasses kits that include these reagent compositions and methods for their use.

Career Highlights

Throughout his career, Menno Cornelis Van Zelm has worked with prestigious institutions, including Erasmus University Medical Center Rotterdam. His research has been pivotal in enhancing diagnostic techniques in immunology. His innovative approaches have garnered attention in the scientific community, contributing to advancements in patient care.

Collaborations

Menno has collaborated with esteemed colleagues such as Jacobus Johannes Maria Van Dongen and José Alberto Orfao De Matos Correia E Vale. These collaborations have further enriched his research and development efforts in the field of immunodeficiencies.

Conclusion

Menno Cornelis Van Zelm's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the diagnosis and understanding of primary immunodeficiencies, showcasing the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…